亿胜生物科技(01061)于2026年8月21日公告称，公司在香港联交所场内回购股份。是次回购数量为1.80万股普通股，对应已发行股本约0.00318%。每股回购价格为2.30港元，支付总金额约4.14万港元。
回购完成后，公司已发行股本由2026年8月19日的565,180,000股变更为565,162,000股，库藏股数由1,826,000股增加至1,844,000股。公司同时披露，本次回购基于股东于2026年5月26日通过的回购授权，该授权可回购的股份总数上限为56,700,600股。截至目前，公司已于市场回购1,844,000股，占授权通过时已发行股本的0.32522%。
公司确认已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的规定。公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.